CareDx, Inc. - Common Stock (NQ:CDNA)

18.53 -0.88 (-4.53%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 5, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about CareDx, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

SHORE Study Demonstrates HeartCare's Prognostic Value for Heart Transplant Recipients, Published in Journal of Heart and Lung Transplantation

November 24, 2025

From CareDx, Inc.

Via Business Wire

CareDx to Participate in Upcoming Investor Conferences

November 10, 2025

From CareDx, Inc.

Via Business Wire

CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

November 07, 2025

From CareDx, Inc.

Via Business Wire

Earnings Scheduled For November 4, 2025 ↗

November 04, 2025

Via Benzinga

4 Analysts Assess CareDx: What You Need To Know ↗

September 23, 2025

Via Benzinga

Earnings Scheduled For August 6, 2025 ↗

August 06, 2025

Via Benzinga

CareDx Announces New Precision Kidney Transplant Data and Product Innovations at ASN Kidney Week 2025

November 06, 2025

From CareDx, Inc.

Via Business Wire

3 Analysts Have This To Say About CareDx ↗

November 06, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 05, 2025

Via Benzinga

What's going on in today's after hours session ↗

November 04, 2025

Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session.

Via Chartmill

CareDx Announces Third Quarter 2025 Financial Results

November 04, 2025

From CareDx, Inc.

Via Business Wire

CareDx Announces Appointment of Jeffrey John Teuteberg, MD as Chief Medical Officer

October 27, 2025

From CareDx, Inc.

Via Business Wire

CareDx Announces Largest Landmark Study of Its Kind on Antibody Mediated Rejection in Heart Transplantation Published in Journal of the American College of Cardiology: Heart Failure

October 23, 2025

From CareDx, Inc.

Via Business Wire

CareDx Announces Appointment of Suresh Gunasekaran to Board of Directors

October 22, 2025

From CareDx, Inc.

Via Business Wire

CareDx to Report Third Quarter 2025 Financial Results on November 4, 2025

October 21, 2025

From CareDx, Inc.

Via Business Wire

CareDx Announces New IVD Products and IVDR Certification for AlloSeq® Tx and QTYPE® at the 2025 American Society of Histocompatibility & Immunogenetics Annual Meeting

October 06, 2025

From CareDx, Inc.

Via Business Wire

CareDx Issues Comment Letter on Draft LCD Policy

September 02, 2025

From CareDx, Inc.

Via Business Wire

CareDx Battles Reimbursement Uncertainty As Market Overlooks Long-Term Potential ↗

August 26, 2025

CareDx, Inc. faces uncertainty with proposed reimbursement changes, but has long-term potential in the $8 billion transplant solutions market.

Via Benzinga

This Actuate Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday ↗

August 26, 2025

Via Benzinga

CareDx to Participate in Wells Fargo Healthcare Conference

August 21, 2025

From CareDx, Inc.

Via Business Wire

CareDx (CDNA) EPS Beats Sales Gain 14% ↗

August 06, 2025

Via The Motley Fool

CareDx Inc (NASDAQ:CDNA) Posts Mixed Q2 2025 Results Amid Revenue Adjustments and Testing Growth ↗

August 06, 2025

CareDx Inc (CDNA) reported mixed Q2 2025 results with revenue of $86.7M, missing estimates, but adjusted revenue rose 14% YoY. Testing volumes grew 13%, while shares fell 6.8% post-earnings.

Via Chartmill

CareDx Announces Appointment of Nathan Smith as Chief Financial Officer

August 06, 2025

From CareDx, Inc.

Via Business Wire

CareDx Announces Second Quarter 2025 Financial Results

August 06, 2025

From CareDx, Inc.

Via Business Wire

CareDx Announces Landmark KOAR Study Published in the American Journal of Transplantation

August 06, 2025

From CareDx, Inc.

Via Business Wire

CareDx Announces Landmark Data in AI-Powered Transplant Diagnostics Showcased in Over 40 Abstracts and 16 Oral Presentations at the 2025 World Transplant Congress

July 31, 2025

From CareDx, Inc.

Via Business Wire

CareDx to Report Second Quarter 2025 Financial Results

July 23, 2025

From CareDx, Inc.

Via Business Wire

CareDx Announces Proposed Draft LCD That Affirms Surveillance Testing Coverage for Solid Organ Transplant Rejection

July 18, 2025

From CareDx, Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 17, 2025

Via Benzinga

Here are the top movers in Thursday's session. ↗

July 17, 2025

Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.

Via Chartmill

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.